Autoimmune Disease Diagnosis Market: Global Industry Analysis and Forecast (2023-2029)


Autoimmune Disease Diagnosis Market is expected to grow at a CAGR of 8% during the forecast period. Autoimmune Disease Diagnosis Market is expected to reach US$ 8.18 Bn. by 2029.

No single test can diagnose most autoimmune diseases; many doctors use a combination of tests and a review of symptoms and physical examination to diagnose patients. The antinuclear antibody test (ANA) is often one of the first tests that doctors use when symptoms suggest an autoimmune disease.

Autoimmune diseases are relatively common for instance, more than 23.5 million people in the United States have at least one autoimmune condition. They are a leading cause of death and disability. This factor is increasing the need for the autoimmune disease diagnosis market.Autoimmune Disease Diagnosis MarketTo know about the Research Methodology :- Request Free Sample Report

Autoimmune Disease Diagnosis Market Dynamics:

Autoimmune Disease Diagnosis Market to be driven by Rising Occurrence of Infectious Diseases

The market for Autoimmune Disease Diagnosis is showing a Northward trend. Epidemic outbreaks of infectious pathogens resulting in a rise in demand for Autoimmune Disease Diagnosis. The market is growing thanks to rising awareness of autoimmune diseases, a high prevalence of autoimmune diseases, and comprehensive research on autoimmune diseases.

Innovative research methods that provide results in a short amount of time, as well as the advent of new market players with novel technology, high precision, and ease of use, are posing a challenge to the Autoimmune Disease Diagnosis market's growth and posing a tough challenge to well-established key players. Initiatives to raise awareness about antimicrobial resistance and how to counter it has created many lucrative opportunities for the key players operating in this market.

The market's growth has been fueled by the government's comprehensive research and development programs for treatment methods, which are specifically aimed at developing superior diagnosis. According to the International Diabetes Federation's 2017 (IDF) estimate, the global diabetes population could reach 629 million by 2045, with approximately 425 million adults (20-79 years) suffering from the disease in 2017.

The report has profiled twenty five key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. The manufacturing environment in each region is different and focus is given on the regional impact on the cost of manufacturing, supply chain, availability of raw materials, labor cost, availability of advanced technology, trusted vendors are analysis and report has come up with recommendations for a future hot spot in the North America. Major country’s policies about manufacturing and their impact on Autoimmune Disease Diagnosis demand are covered in the report.

Autoimmune Disease Diagnosis Market Segment Analysis

The consumables & assay kits segment is expected grow at a CAGR of 8% during the forecast period.

Based on the product, in 20, the consumables & assay kits products segment holds the largest market share of xx% in 2022 and it is estimated to reach USD$ xx Mn by 2029. The rising occurrence of autoimmune disease, as well as the growing number of product launches/approvals, have boosted market growth. With the development and identification of SARCS - CoV 2 and Covid – 19 pandemic has increased the need for the consumable & assay kit market. In addition, the rising number of autoimmune diseases and increasing number of product launches and government approvals are supporting the market growth.

Autoimmune Disease Diagnosis Market

Autoimmune Disease Diagnosis Market Regional Insights:

Europe to witness high market growth rate and is expected to grow at a CAGR of 8% by 2029

The Europe market for Autoimmune Disease Diagnosis is expected to rise at a faster pace than the rest of the world by 2029. The main factors driving market growth in North America are growing prevalence of infectious diseases, increased R&D to build novel automated AST systems, technological advances, and safety concerns. Increased geriatric population and chronic disease incidences are two major factors driving the autoimmune disease diagnosis industry's development in Europe. Furthermore, most of the world's leading corporations, such as Grifols, EUROIMMUN AG, Trinity Biotech, Werfen, and Oncimmune headquartered in the area or have a significant presence there. Others have concentrated on growth in order to broaden their scope and capabilities. Another important factor contributing to the market's rapid expansion is this factor.

The objective of the report is to present a comprehensive analysis of the global Autoimmune Disease Diagnosis market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the global Autoimmune Disease Diagnosis market dynamics, structure by analyzing the market segments and project the global Autoimmune Disease Diagnosis market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Autoimmune Disease Diagnosis market make the report investor’s guide.

Covid-19 Impact:

COVID-19 Impact on the global Autoimmune Disease Diagnosis market

The governments of all Covid-19-affected countries are most concerned about testing large numbers of patients for potential Sars-Cov-2 infection. As a result, the majority of them are experiencing severe shortages of testing kits to screen for the virus. Labs in a number of countries are requesting more in-vitro or point-of-care testing capabilities, and Diagnostics virology entities are under tremendous pressure to provide accurate testing kits.

Autoimmune Disease Diagnosis Market Scope: Inquire before buying






Autoimmune Disease Diagnosis Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2017 to 2022
Market Size in 2022:
US $ 4.77 Bn.




Forecast Period 2023 to 2029 CAGR:
8%
Market Size in 2029:
US $ 8.18 Bn.




 Segments Covered:
by Product
• Consumables & Assay Kits
• Instruments




by Test Type
• Routine Laboratory Tests
• Inflammatory Markers
• Autoantibodies & Immunologic Test
• Other Tests




by Disease
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus
• Sjogren’s Syndrome
• Thyroiditis
• Scleroderma
• Other Diseases




by End-User
• Clinical Laboratories
• Hospitals
• Other End Users






Autoimmune Disease Diagnosis Market, by Region

• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)

Autoimmune Disease Diagnosis Market Key Players

• Thermo Fisher Scientific
• Siemens
• Abbott
• Danaher
• Bio-Rad Laboratories
• Grifols
• Trinity Biotech
• Werfen
• HYCOR Biomedical
• EUROIMMUN AG
• Oncimmune
• HTG Molecular Diagnostics
• Seramun Diagnostica GmbH
• Exagen Inc.
• Cambridge Life Sciences Limited
• A. Menarini Diagnostics s.r.l
• ORGENTEC Diagnostika
• KRONUS
• AESKU GROUP GMBH & CO. KG
• Other key players

Frequently Asked Questions:

1. Which region has the largest share in Global Autoimmune Disease Diagnosis Market?
Ans: Europe region held the highest share in 2022.

2. What is the growth rate of Global Autoimmune Disease Diagnosis Market?
Ans: The Global Autoimmune Disease Diagnosis Market is growing at a CAGR of 8% during forecasting period 2023-2029.

3. What is scope of the Global Autoimmune Disease Diagnosis Market report?
Ans: Global Autoimmune Disease Diagnosis Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Autoimmune Disease Diagnosis Market?
Ans: The important key players in the Global Autoimmune Disease Diagnosis Market are – Thermo Fisher Scientific, Siemens, Abbott, Danaher, Bio-Rad Laboratories, Grifols, Trinity Biotech, Werfen, HYCOR Biomedical, EUROIMMUN AG, Oncimmune, HTG Molecular Diagnostics, Seramun Diagnostica GmbH, Exagen Inc., Cambridge Life Sciences Limited, A. Menarini Diagnostics s.r.l, ORGENTEC Diagnostika, KRONUS, AESKU GROUP GMBH & CO. KG, Other key players

5. What is the study period of this Market?
Ans: The Global Autoimmune Disease Diagnosis Market is studied from 2022 to 2029. 




1. Preface
1.1. Market Definition and Key Research Objectives
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Autoimmune Disease Diagnosis Market Size, by Market Value (US$ Mn)
3.1. Global Market Segmentation
3.2. Global Market Segmentation Share Analysis, 2022
3.2.1. Global
3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
3.3. Geographical Snapshot of the Autoimmune Disease Diagnosis Market
3.4. Geographical Snapshot of the Autoimmune Disease Diagnosis Market, By Manufacturer share
4. Global Autoimmune Disease Diagnosis Market Overview, 2022-2029
4.1. Market Dynamics
4.1.1. Drivers
4.1.1.1. Global
4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.2. Restraints
4.1.2.1. Global
4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.3. Opportunities
4.1.3.1. Global
4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.4. Challenges
4.1.4.1. Global
4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.5. Industry Trends and Emerging Technologies
4.1.6. Porters Five Forces Analysis
4.1.6.1. Threat of New Entrants
4.1.6.2. Bargaining Power of Buyers/Consumers
4.1.6.3. Bargaining Power of Suppliers
4.1.6.4. Threat of Substitute Products
4.1.6.5. Intensity of Competitive Rivalry
4.1.7. Value Chain Analysis
4.1.8. Technological Roadmap
4.1.9. Regulatory landscape
4.1.10. Impact of the Covid-19 Pandemic on the Global Autoimmune Disease Diagnosis Market
5. Supply Side and Demand Side Indicators
6. Global Autoimmune Disease Diagnosis Market Analysis and Forecast, 2022-2029
6.1. Global Autoimmune Disease Diagnosis Market Size & Y-o-Y Growth Analysis.
7. Global Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
7.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
7.1.1. Consumables & Assay Kits
7.1.2. Instruments
7.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
7.2.1. Routine Laboratory Tests
7.2.2. Inflammatory Markers
7.2.3. Autoantibodies & Immunologic Test
7.2.4. Other Tests
7.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
7.3.1. Rheumatoid Arthritis
7.3.2. Systemic Lupus Erythematosus
7.3.3. Sjogren’s Syndrome
7.3.4. Thyroiditis
7.3.5. Scleroderma
7.3.6. Other Diseases
7.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
7.4.1. Clinical Laboratories
7.4.2. Hospitals
7.4.3. Other End Users
8. Global Autoimmune Disease Diagnosis Market Analysis and Forecasts, By Region
8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029
8.1.1. North America
8.1.2. Europe
8.1.3. Asia-Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9. North America Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
9.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
9.1.1. Consumables & Assay Kits
9.1.2. Instruments
9.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
9.2.1. Routine Laboratory Tests
9.2.2. Inflammatory Markers
9.2.3. Autoantibodies & Immunologic Test
9.2.4. Other Tests
9.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
9.3.1. Rheumatoid Arthritis
9.3.2. Systemic Lupus Erythematosus
9.3.3. Sjogren’s Syndrome
9.3.4. Thyroiditis
9.3.5. Scleroderma
9.3.6. Other Diseases
9.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
9.4.1. Clinical Laboratories
9.4.2. Hospitals
9.4.3. Other End Users
10. North America Autoimmune Disease Diagnosis Market Analysis and Forecasts, By Country
10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
10.1.1. US
10.1.2. Canada
10.1.3. Mexico
11. U.S. Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
11.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
11.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
11.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
11.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
12. Canada Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
12.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
12.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
12.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
12.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
13. Mexico Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
13.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
13.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
13.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
13.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
14. Europe Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
14.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
14.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
14.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
14.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
15. Europe Autoimmune Disease Diagnosis Market Analysis and Forecasts, By Country
15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
15.1.1. U.K
15.1.2. France
15.1.3. Germany
15.1.4. Italy
15.1.5. Spain
15.1.6. Sweden
15.1.7. CIS Countries
15.1.8. Rest of Europe
16. U.K. Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
16.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
16.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
16.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
16.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
17. France Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
17.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
17.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
17.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
17.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
18. Germany Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
18.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
18.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
18.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
18.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
19. Italy Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
19.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
19.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
19.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
19.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
20. Spain Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
20.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
20.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
20.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
20.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
21. Sweden Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
21.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
21.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
21.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
21.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
22. CIS Countries Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
22.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
22.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
22.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
22.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
23. Rest of Europe Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
23.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
23.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
23.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
23.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
24. Asia Pacific Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
24.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
24.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
24.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
24.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
25. Asia Pacific Autoimmune Disease Diagnosis Market Analysis and Forecasts, by Country
25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
25.1.1. China
25.1.2. India
25.1.3. Japan
25.1.4. South Korea
25.1.5. Australia
25.1.6. ASEAN
25.1.7. Rest of Asia Pacific
26. China Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
26.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
26.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
26.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
26.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
27. India Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
27.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
27.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
27.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
27.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
28. Japan Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
28.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
28.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
28.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
28.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
29. South Korea Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
29.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
29.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
29.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
29.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
30. Australia Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
30.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
30.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
30.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
30.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
31. ASEAN Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
31.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
31.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
31.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
31.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
32. Rest of Asia Pacific Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
32.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
32.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
32.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
32.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
33. Middle East Africa Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
33.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
33.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
33.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
33.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
34. Middle East Africa Autoimmune Disease Diagnosis Market Analysis and Forecasts, by Country
34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029
34.1.1. South Africa
34.1.2. GCC Countries
34.1.3. Egypt
34.1.4. Nigeria
34.1.5. Rest of ME&A
35. South Africa Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
35.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
35.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
35.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
35.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
36. GCC Countries Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
36.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
36.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
36.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
36.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
37. Egypt Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
37.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
37.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
37.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
37.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
38. Nigeria Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
38.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
38.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
38.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
38.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
39. Rest of ME&A Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
39.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
39.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
39.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
39.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
40. South America Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
40.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
40.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
40.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
40.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
41. South America Autoimmune Disease Diagnosis Market Analysis and Forecasts, by Country
41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029
41.1.1. Brazil
41.1.2. Argentina
41.1.3. Rest of South America
42. Brazil Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
42.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
42.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
42.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
42.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
43. Argentina Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
43.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
43.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
43.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
43.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
44. Rest of South America Autoimmune Disease Diagnosis Market Analysis and Forecasts, 2022-2029
44.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
44.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029
44.3. Market Size (Value) Estimates & Forecast By Disease, 2022-2029
44.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029
45. Competitive Landscape
45.1. Geographic Footprint of Major Players in the Global Autoimmune Disease Diagnosis Market
45.2. Competition Matrix
45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment
45.2.2. New Product Launches and Product Enhancements
45.2.3. Market Consolidation
45.2.3.1. M&A by Regions, Investment and Verticals
45.2.3.2. M&A, Forward Integration and Backward
Integration
45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
45.3. Company Profile : Key Players
45.3.1. Thermo Fisher Scientific
45.3.1.1. Company Overview
45.3.1.2. Financial Overview
45.3.1.3. Geographic Footprint
45.3.1.4. Product Portfolio
45.3.1.5. Business Strategy
45.3.1.6. Recent Developments
45.3.2. Siemens
45.3.3. Abbott
45.3.4. Danaher
45.3.5. Bio-Rad Laboratories
45.3.6. Grifols
45.3.7. Trinity Biotech
45.3.8. Werfen
45.3.9. HYCOR Biomedical
45.3.10. EUROIMMUN AG
45.3.11. Oncimmune
45.3.12. HTG Molecular Diagnostics
45.3.13. Seramun Diagnostica GmbH
45.3.14. Exagen Inc.
45.3.15. Cambridge Life Sciences Limited
45.3.16. A. Menarini Diagnostics s.r.l
45.3.17. ORGENTEC Diagnostika
45.3.18. KRONUS
45.3.19. AESKU GROUP GMBH & CO. KG
45.3.20. Other key players
46. Primary Key Insights
  • INQUIRE BEFORE BUYING